Potential clinical implications of molecular mimicry‐induced autoimmunity
Immunity, Inflammation and Disease · 2024-02 · 12 (2)
DOI: 10.1002/iid3.1178 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 01.02.2024. Verfasst von Bandar A Suliman. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Autoimmune Diseases. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Molecular mimicry is hypothesized to be a mechanism by which autoimmune diseases are triggered. It refers to sequence or structural homology between foreign antigens and self‐antigens, which can activate cross‐reactive lymphocytes that attack host tissues. Elucidating the role of molecular mimicry in human autoimmunity could have important clinical implications.
Objective
To review evidence for the role of molecular mimicry in major autoimmune diseases and discuss potential clinical implications.
Methods
Comprehensive literature review of clinical trials, observational studies, animal models, and immunology studies on molecular mimicry in multiple sclerosis, type 1 diabetes, rheumatoid arthritis, lupus, Guillain‐Barre syndrome, autoimmune myocarditis, and primary biliary cirrhosis published from 2000–2023.
Results
Substantial indirect evidence supports molecular mimicry as a contributor to loss of self‐tolerance in several autoimmune conditions. Proposed microbial triggers include Epstein‐Barr virus, coxsackievirus, Campylobacter jejuni, and bacterial commensals. Key mechanisms involve cross‐reactive T cells and autoantibodies induced by epitope homology between microbial and self‐antigens. Perpetuation of autoimmunity involves epitope spreading, inflammatory mediators, and genetic factors.
Conclusions
Molecular mimicry plausibly explains initial stages of autoimmune pathogenesis induced by infection or microbiota disturbances. Understanding mimicry antigens and pathways could enable improved prediction, monitoring, and antigen‐specific immunotherapy for autoimmune disorders. However, definitive proof of causation in humans remains limited. Further research should focus on establishing clinical evidence and utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia.
Zitieren
APA
Suliman, B. A. (2024). Potential clinical implications of molecular mimicry‐induced autoimmunity. Immunity, Inflammation and Disease, 12(2). https://doi.org/10.1002/iid3.1178
Vancouver
Suliman BA. Potential clinical implications of molecular mimicry‐induced autoimmunity. Immunity, Inflammation and Disease. 2024;12(2). doi:10.1002/iid3.1178
BibTeX
@article{Suliman2024,
author = {Suliman, Bandar A},
title = {Potential clinical implications of molecular mimicry‐induced autoimmunity},
journal = {Immunity, Inflammation and Disease},
year = {2024},
volume = {12},
number = {2},
doi = {10.1002/iid3.1178}
}
EUVIMED